Solid Biosciences Inc.
SLDB
$9.54
-$0.39-3.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -34.41% | -37.30% | -39.80% | -63.16% | -69.90% |
| Total Depreciation and Amortization | -3.38% | -35.94% | -33.36% | -23.99% | -28.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.02% | 7.93% | 19.82% | 126.08% | 302.27% |
| Change in Net Operating Assets | -282.72% | -184.15% | -339.37% | 577.99% | 223.87% |
| Cash from Operations | -52.38% | -60.93% | -56.27% | -45.17% | -43.61% |
| Capital Expenditure | -33.66% | -88.91% | -76.30% | -46.67% | 20.48% |
| Sale of Property, Plant, and Equipment | 1,600.00% | 1,600.00% | 1,600.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -170.27% | 435.53% | -271.74% | -649.85% | -44.35% |
| Cash from Investing | -167.02% | 372.13% | -263.38% | -614.98% | -41.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 15.05% | 3.29% | -52.85% | -87.83% | -133.33% |
| Issuance of Common Stock | 53.55% | 25.77% | 53.76% | 63.49% | 69.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -711.66% | -4,655.23% | 67.11% | 67.11% | 67.11% |
| Cash from Financing | 48.15% | 18.94% | 58.81% | 69.17% | 75.90% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -53.86% | -7.89% | -420.19% | -119.65% | 887.92% |